The effect of 10-hydroxycamptothecine in preventing fibroblast proliferation and epidural scar adhesion after laminectomy in rats

European Journal of Pharmacology

Volumn 593, Issue 1-3, 2008, Pages 44-48

  Sun, Yu ^a   Wang, Lei ^a   Sun, Sixin ^a   Liu, Bo ^a   Wu, Naiqing ^a   Cao, Xiaojian ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

10 Hydroxycamptothecin; Epidural adhesion; Fibroblast; Laminectomy

Indexed keywords

10 HYDROXYCAMPTOTHECIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; EPIDURAL SPACE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LAMINECTOMY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SCAR FORMATION;

ADHESIONS; ADMINISTRATION, TOPICAL; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CELL PROLIFERATION; CICATRIX; EPIDURAL SPACE; FIBROBLASTS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; INDICATORS AND REAGENTS; LAMINECTOMY; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 49749105571     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.07.028     Document Type: Article

References (36)

1. Abelson H.T., and Penman S. Selective interruption of high molecular weight RNA synthesis in HeLa cells by camptothecin. Nat. New. Biol. 237 (1972) 144-146
2. Abitbol J.J., Lincoln T.L., Lind B.I., Amiel D., Akeson W.H., and Garfin S.R. Preventing postlaminectomy adhesion. A new experimental model. Spine 19 (1994) 1809-1814
3. Bailly C. Topoisomerase I poisons and suppressors as anticancer drugs. Curr. Med. Chem. 7 (2000) 39-58
4. Barbera J., Gonzalez J., Esquerdo J., Broseta J., and Barcia-Salorio J.L. Prophylaxis of the laminectomy membrane. An experimental study in dogs. J. Neurosurg. 49 (1978) 419-424
5. Beretta G.L., Perego P., and Zunino F. Mechanisms of cellular resistance to camptothecins. Curr. Med. Chem. 13 (2006) 3291-3305
6. Butler J., Rydell N.W., and Balazs E.A. Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of arthritis in track horses. Acta.Vet. Scand. 11 (1970) 139-155
7. Burton C.V., Kirkaldy-Willis W.H., Yong-Hing K., and Heithoff K.B. Causes of failure of surgery on the lumbar spine. Clin. Orthop. Relat.Res. 157 (1981) 191-199
8. Cook S.D., Prewett A.B., Dalton J.E., and Whitecloud T.S. Reduction in perineural scar formation after laminectomy with polyactive membrane sheets. Spine 19 (1994) 1815-1825
9. Darzynkiewicz Z., Bruno S., Del Bino G., and Traganos F. The cell cycle effects of camptothecin. Ann. N. Y. Acad. Sci. 803 (1996) 93-110
10. Einhaus S.L., Robertson Jr. J.T., Dohan F.C., Wujek J.R., and Ahmad S. Reduction of peridural fibrosis after lumbar laminotomy and discectomy in dogs by a resorbable gel (ADCON-L). Spine 22 (1997) 1440-1447
11. Han R. Highlight on the studies of anticancer drugs derived from plants in China. Stem Cells 12 (1994) 53-63
12. Horwitz S.B., Chang C.K., and Grollman A.P. Studies on camptothecin. I. Effects of nucleic acid and protein synthesis. Mol. Pharmacol. 7 (1971) 632-644
13. Kessel D., Bosmann H.B., and Lohr K. Camptothecin effects on DNA synthesis in murine leukemia cells. Biochim. Biophys. Acta 269 (1972) 210-216
14. Lee H.M., Yang K.H., Han D.Y., and Kim N.H. An experimental study on prevention of postlaminectomy scar formation. Yonsei. Med. J. 31 (1990) 359-366
15. Lee J.Y., Stenzel W., Ebel H., Wedekind C., Ernestus R.I., and Klug N. Mitomycin C in preventing spinal epidural fibrosis in a laminectomy model in rats. J. Neurosurg. 100 (2004) 52-55
16. Ling Y.H., Perez-Soler R., and Tseng M.T. Effect of DNA topoisomerase I inhibitor, 10-hydroxycamptothecin. on the structure and function of nuclei and nuclear matrix in bladder carcinoma MBT-2 cells. Anticancer. Res. 13 (1993) 1613-1617
17. Liu L.F., Desai S.D., Li T.K., Mao Y., Sun M., and Sim S.P. Mechanism of action of camptothecin. Ann. N. Y. Acad. Sci. 922 (2000) 1-10
18. Maroon J.C., Abla A., and Bost J. Association between peridural scar and persistent low back pain after lumbar discectomy. Neurol. Res. 21 (1999) S43-S46
19. Miao D., and Scutt A. Histochemical localization of alkaline phosphatase activity in decalcified bone and cartilage. J. Histochem. Cytochem. 50 (2002) 333-340
20. North R.B., Ewend M.G., Lawton M.T., Kidd D.H., and Piantadosi S. Failed back surgery syndrome: 5 year follow-up in 102 patients undergoing repeated operation. Neurosurgery 28 (1991) 685-691
21. Osheroff N. Biochemical basis for the interactions of type I and type II topoisomerases with DNA. Pharmacol. Ther. 41 (1989) 223-241
22. Pommier Y., Pourquier P., Fan Y., and Strumberg D. Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim. Biophys. Acta. 1400 (1998) 83-105
23. Ross J.S., Robertson J.T., Frederickson R.C., Petrie J.L., Obuchowski N., Modic M.T., and deTribolet N. Association between peridural scar and recurrent radicular pain after lumbar discectomy: magnetic resonance evaluation. Neurosurgery 38 (1996) 855-863
24. Rydell N. Decreased granulation tissue reaction after installment of hyaluronic acid. Acta. Orthop. Scand. 41 (1970) 307-311
25. Songer M.N., Rauschning W., Carson E.W., and Pandit S.M. Analysis of peridural scar formation and its prevention after lumbar laminotomy and discectomy in dogs. Spine 20 (1995) 71-580
26. Soret J., Gabut M., Dupon C., Kohlhagen G., Stévenin J., Pommier Y., and Tazi J. Altered serine/arginine-rich protein phosphorylation and exonic enhancer-dependent splicing in mammalian cells lacking topoisomerase I. Cancer. Res. 63 (2003) 8203-8211
27. Sun Y., Wang L.X., Wang L., Sun S.X., Cao X.J., Wang P., and Feng L. A comparison of the effectiveness of mitomycin C and 5-fluorouracil in the prevention of peridural adhesion after laminectomy. J. Neurosurg. Spine 7 (2007) 423-428
28. Tatsumura T., Yamamoto K., Murakami A., Tsuda M., and Sugiyama S. New chemotherapeutic method for the treatment of tracheal and bronchial cancers-nebulization chemotherapy. Gan. No. Rinsho. 29 (1983) 765-770
29. Ulukan H., and Swaan P.W. Camptothecins: a review of their chemotherapeutic potential. Drugs. 19 (2002) 2039-2057
30. Wall M.E., and Wani M.C. Camptothecin and taxol: discovery to clinic-thirteenth Bruce F. Cain Memorial Award Lecture. Cancer. Res. 55 (1995) 753-760
31. Wall M.E., Wani M.C., Cook C.E., Palmer K.H., Mcphail H.T., and Sim G.A. Plant antitumor agents. I: the isolation and structure of camptothecin, a novel alkoloidal leukemia and tumor inhibitor from Camptotheca accuminata. J. Am. Chem. Soc. 88 (1966) 3888-3890
32. Wang S.L., Lin S.Y., Hsieh T.F., and Chan S.A. Thermal behavior and thermal decarboxylation of 10-hydroxycamptothecin in the solid state. J. Pharm. Biomed. Anal. 43 (2007) 457-463
33. Wani M.C., Ronman P.E., Lindley J.T., and Wall M.E. Plant antitumor agents. 18. Synthesis and biological activity of camptothecin analogues. J. Med. Chem. 23 (1980) 554-560
34. Zhang R., Li Y., Cai Q., Liu T., Sun H., and Chambless B. Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I. Cancer. Chemother. Pharmacol. 41 (1998) 257-267
35. Zunino F., and Pratesi G. Camptothecins in clinical development. Expert. Opin. Investig. Drugs 13 (2004) 269-284
36. Zunino F., Dallavalle S., Laccabue D., Beretta G., Mwelini L., and Pratesi G. Current status and perspectives in the development of camptothecins. Curr. Pharm. Des. 8 (2002) 2505-2520